Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Ann Neurol. 2008 Nov;64(5):514–522. doi: 10.1002/ana.21491

Table 4.

Most Frequently Reported Adverse Events (Safety Population)

Adverse Eventsa Patients (N = 29), n (%)
Diarrhea 21 (72)
Tremor 11 (38)
Abdominal pain 10 (34)
Cough 10 (34)
Pyrexia 8 (28)
Weight decreased 7 (24)
Nasopharyngitis 7 (24)
Vomiting 6 (21)
Convulsions 6 (21)
Headache 6 (21)
Activated partial thromboplastin time prolonged 6 (21)
Aspartate aminotransferase increased 6 (21)

aAdverse events that occurred in at least 20% of patients.